Breaking News

inVentiv Health Names Clinical Ops EVP

December 18, 2012

Stansfield to lead development in Europe, Asia-Pac, and Latin America

Dr. Susan C. Stansfield has joined PharmaNet/i3, inVentiv Health’s clinical segment, as executive vice president of Clinical Operations for Phase II-IV Development in Europe, Middle East, and Africa (EMEA), Asia-Pacific, and Latin America. 
 
Dr. Stansfield has successfully held senior leadership positions at other global clinical research organizations and has a proven record of significantly enhancing clinical operations.
 
“This appointment demonstrates PharmaNet/i3’s commitment to enhancing support for regional operations in parallel to our global cross-functional project management team,” said Dr. Robert M. Reekie, chief operating officer, Phase II-IV Development. “We believe Susan is a great addition to our talented global team that is focused on delivering the best possible service to our clients.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.